Literature DB >> 3227989

Premenstrual increase of intracellular magnesium levels in women with ovulatory, asymptomatic menstrual cycles.

F Facchinetti1, P Borella, M Valentini, L Fioroni, A R Genazzani.   

Abstract

Intracellular magnesium (Mg) levels regulate several enzymatic reactions and the hypoactivity of Mg has been involved in different pathological states. In addition to other factors, gonadal hormones, too, have been found to interfere in Mg balance. This study evaluates the changes in Mg in women throughout the normal menstrual cycle and those measured at weekly intervals in males. Magnesium and potassium (K) levels were measured in the plasma, red blood cells (RBC), lymphocytes (LC) and polymorphonucleated cells (PMN) of 11 normal menstruating women, in different periods of their menstrual cycle. Blood samples were collected every 4th day. According to the time and LH, progesterone and estradiol levels, they were classed as follicular (Foll), periovulatory (OV), luteal (Lut) or premenstrual (PM). The Menstrual Distress Questionnaire completed by the subjects revealed that no significant symptomatology was present. Four blood samples were also collected from 4 normal males, at weekly intervals. Mg and K were determined by atomic absorption spectrophotometry. LC and PMN were purified by centrifugation on a Ficoll discontinuous gradient. No differences were found in males versus females in the Mg or K contents in the different compartments. In the 4 periods tested, the K levels were constant, in both females and males. The same applies for Mg contents in males. In females, Mg contents, as well as the Mg/K ratio in LC and PMN, showed a significant increase in the premenstrual period compared with the other periods of the cycle. On the contrary, plasma and RBC Mg levels were constant throughout the cycle.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3227989     DOI: 10.3109/09513599809029349

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  2 in total

1.  Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome.

Authors:  S Quaranta; M A Buscaglia; M G Meroni; E Colombo; S Cella
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

2.  Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk.

Authors:  Maria C Mora-Pinzon; Amy Trentham-Dietz; Ronald E Gangnon; Scott V Adams; John M Hampton; Elizabeth Burnside; Martin M Shafer; Polly A Newcomb
Journal:  Nutr Cancer       Date:  2018-03-14       Impact factor: 2.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.